The Ocular Surfactant System and its Relevance in the Dry Eye;Das okuläre Surfactant-System und dessen Rolle bei entzündlichen Erkrankungen der Augenoberfläche

Klinische Monatsblatter fur Augenheilkunde

Volumn 227, Issue 11, 2010, Pages 864-870

  Schicht, M ^a   Posa, A ^a   Paulsen, F ^b   Brauer L ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

lacrimal apparatus; ocular surface; surfactant proteins; tear film

Indexed keywords

SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

ANTIMICROBIAL ACTIVITY; DRY EYE; HOST RESISTANCE; HUMAN; LACRIMAL GLAND; LUNG; PROTEIN FUNCTION; REVIEW; TEAR FILM;

DRY EYE SYNDROMES; HUMANS; LACRIMAL APPARATUS; LUNG; PULMONARY SURFACTANTS; RHEOLOGY; TEARS;

EID: 78349262746     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1245609     Document Type: Review

References (83)

1. Resnikoff S, Pascolini D, Mariottia S et al. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bulletin of the World Health Organization 2008 86 63-70
2. De Paiva C, Chen Z, Koch D et al. The Incidence and Risk Factors for Developing Dry Eye After Myopic LASIK. American Journal of Ophthalmology 141 Issue 3 438-445
3. Michael A. Lemp Advances in Understanding and Managing Dry Eye Disease. American Journal of Ophthalmology 2008
4. McDonald M. With LASIK, roughly half of my patients had dry eye complaints after surgery and in about half of these, the symptoms were severe. December 2005 RefractiveEyecare.com
5. Khali M B., Latkany R A., Speaker M G. et al. Effect of Punctal Plugs in Patients With Low Refractive Errors Considering Refractive Surgery. Journal of Refractive Surgery 2007 23 (5) 467-471
6. Baum J. Infections of the eye. Clin Infect Dis 1995 21 479-488
7. Gritz D C., Whitcher J P. Topical issues in the treatment of bacterial keratitis. Int Ophthaomol Clin 1998 38 107-114
8. Brennan N A., Chantal Coles M L. Extended wear in perspective. Invest Ophthalmol Vis Sci 1997 74 609-623
9. Levartovsky S, Rosenwasser G, Goodman D. Bacterial keratitis following laser in situ keratomileusis. Ophthalmology 2001 108 321-325
10. Fleiszig S MJ, Efron N, Pier G B. Extended contact lens wear enhances Pseudomonas aeruginosa adherence to human conrneal epithelium. Invest Ophthalmol Vis Sci 1992 33 2908-2916
11. v Brandis H J. Anatomie und Physiologie für Krankenschwestern und andere Medizinalberufe. Fischer Stuttgart, New York 1985 6. Aufl
12. Souza G A., Godoy L M., Mann M de. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol 2006 7 (8) R72 Epub 2006 Aug 10
13. Fleming A. On a remarkable bacteriolytic element found in tissues and secretions. Proc R Soc B 1922 93 306-317
14. Pleyer U, Baatz H. Antibacterial protection of the ocular surface. Ophthalmologica 1997 211 (Suppl 1) 2-8
15. Oram J, Reiter B. Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochim Biophys Acta 1979 170 351-353
16. Kijlstra A. The role of lactoferrin in the nonspecific immune response on the ocular surface. Regul Immunol 1990 3 193-197
17. Fluckinger M, Haas H, Merschak P et al. Human tear lipocalin exhigits antimicrobial activity by scavenging microbial siderophores. Antimicrob Agents Chem 2004 48 3367-3372
18. Mudgil P, Millar T J. Adsorption of apo- and holo-tear lipocalin to a bovine Meibomian lipid film. TJ Exp Eye Res 2008 86 (4) 622-628 Jan 12 Jan 12. Epub 2008
19. Qu X D., Lehrer R I. Secretory phospholipase A 2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect Immun 1998 66 2791-2799
20. Girgis D O., Dajcs J J., OCallaghan R J. Phospholipase A 2 activity in normal and Staphylococcus aureus-infected rabbit eyes. Invest Ophthalmol Vis Sci 2003 44 197-202
21. Garreis F, Schlorf T, Worlitzsch D et al. Expanding the Roles of Human-Defensins in Innate Immune Defense at the Ocular Surface: Arming and Alarming Corneal and Conjunctival Epithelial Cells. Investigative Ophthalmology & Visual Science (IOVS) (in press)
22. Dermott A M. Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf 2004 2 229-247
23. Fearson D, Austen K. The alternative pathway of complement: A system for host resistance to microbial infection. N Engl J Med 1980 303 259-261
24. Qureshi S T., Gros P, Malo D. Host resistance to infection: Genetic control of ipopolysaccharide responsiveness by TOLL-like receptor genes. Elsevier Science: S 0168 9525(99)01 782 - 5 TIG 1999
25. Paulsen F, Varoga D, Steven P et al. Antimicrobial peptides at the ocular surface. In Zierhut M Stern M E. Sullivan D A. (eds) Immunology of Lacrimal Gland and Tear Film. London Taylor & Francis 2005 97-104
26. Garreis F, Gottschalt M, Paulsen F. Antimicrobial peptides as major part of the innate immune defense at the ocular surface. In Brewitt H (ed) Research projects in dry eye syndrome. Basel Dev Ophthalmol, Karger (in press), 2010
27. Bräuer L, Kindler C, Jäger K et al. Detection of surfactant proteins A and D in human tear fluid and the human lacrimal system. Invest Ophthalmol Vis Sci 2007 48 3945-3953
28. Bräuer L, Börgermann J, Johl M et al. Detection and localization of the hydrophobic surfactant proteins B and C in human tear fluid and the human lacrimal system. Curr Eye Res 2007 32 931-938
29. Von Neegaard K. Neue Auffassungen über einen Grundbegriff der Atemmechanik. ZGesamte Exp Med 1929 66 373-394
30. Klaus M H., Clements J A., Havel R J. Composition of surface-active material isolatedfrom beef lung. Proc Natl Acad Sci USA 1961 47 1858-1859
31. King R J., Klass D J., Gikas E G. Isolation of apoproteins from canine surface active material. Am J Pathol 1973 224 788-795
32. Van Iwaarden F, Welmers B, Verhoef J et al. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990 2 91-98
33. Polin R A., Fox W W. Fetal and neonatal physiology. (3rd ed.) 1997 1275-1283
34. Nogee L M. Genetics of the hydrophobic surfactant proteins. Biochim Biophy Acta 1998 1408 323-333
35. Voorhout W F., Veenendaal T, Haagsman H P. et al. Intracellular processing of pulmonary surfactant protein B in an endosomal/lysosomal compartment. Am J Physiol 1992 263 479-486
36. Crouch E, Wright J R. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001 63 521-554
37. Creuwels L AJM, Golde L MG, Haagsman H P. The pulmonary surfactant system:biochemical and clinical aspects. Lung 1997 175 1-39
38. Cole F S., Hamvas A van, Nogee L M. Genetic disorders of neonatal respiratory function. Ped Res 2001 50 157-162
39. Kobayashi T, Nitta K, Takahashi R et al. Activity of pulmonary surfactant after blocking the associated proteins SP-A and SP-B. J Appl Physiol 1991 71 530-536
40. Korfhagen T R., Bruno M D., Ross G F. et al. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci U S A 1996 93 9594-9599
41. Van Iwaarden F, Welmers B, Verhoef J et al. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990 2 91-98
42. Levine A M., Kurak K E., Bruno M D. et al. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998 19 700-708
43. Hartshorn K L., Crouch E, White M R. et al. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol 1998 274 L958-L969
44. Sastry K, Ezekowitz R A. Collectins: pattern recognition molecules involved in first line host defense. Curr Opin Immunol 1993 5 59-66
45. Ferguson J S., Voelker D R., McCormack F X. et al. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J Immunol 1999 163 312-321
46. Botas C, Poulain F, Akiyama J. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein. D Proc Natl Acad Sci USA 1998 95 11869-11874
47. Wert S E., Yoshida M, LeVine A M. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci USA 2000 23 5972-5977
48. Phizackerley P J., Town M H., Newman G E. Hydrophobic proteins of lamellated osmiophilic bodies isolated from pig lung. Biochem J 1979 183 731-736
49. Yu S H., Chung W, Olafson R W. et al. Characterization of the small hydrophobic proteins associated with pulmonary surfactant. Biochim Biophys Acta 1987 921 437-448
50. Whitsett J A., Hull W M., Ohning B et al. Immunologic identification of a pulmonary surfactant-associated protein of molecular weight = 6000 daltons. Pediatr Res 1986 20 744-749
51. Yu S H., Wallace D, Bhavnani B et al. Effect of reconstituted pulmonary surfactant containing the 6000-dalton hydrophobic protein on lung compliance of prematurely delivered rabbit fetuses. Pediatr Res 1988 23 23-30
52. Whitsett J A., Ohning B L., Ross G et al. Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy. Pediatr Res 1986 20 460-467
53. Possmayer F. A proposed nomenclature for pulmonary surfactantassociated proteins. Am Rev Respir Dis 1988 138 990-998
54. Hawgood S, Shiffer K. Structures and properties of the surfactantassociated proteins. Annu Rev Physiol 1991 53 375-394
55. Glasser S W., Korfhagen T R., Perme C M. et al. Two SP-C genes encoding human pulmonary surfactant proteolipid. J Biol Chem 1988 263 10326-10331
56. Jacobs K A., Phelps D S., Steinbrink et al. Isolation of cDNA clone encoding a high molecular weight precursor to a 6-kDa pulmonary surfactant-associated protein. J Biol Chem 1987 262 9808-9811
57. Yu S H., Possmayer F. Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures. Biochim Biophys Acta 1990 1046 233-241
58. Notter R H., Shapiro D L., Ohning B et al. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein. Chem Phys Lipids 1987 44 1-17
59. Spragg R G., Gilliard N, Richman P. The adult respiratory distress syndrome: clinical aspects relevant to surfactant supplementation. In Robertson B Golde L MG Batenburg JJ eds Pulmonary Surfactant: From Molecular Biology to Clinical Practice. Amsterdam Elsevier 1992 685-703
60. Kobayashi T van, Nitta K, Takahashi R et al. Activity of pulmonary surfactant after blocking the associated proteins SP-A and SP-B. J Appl Physiol 1991 71 530-536
61. Ridsdale R A., Palaniyar N, Possmayer F et al. Formation of folds and vesicles by dipalmitoylphosphatidylcholine monolayers spread in excess. J Membr Biol 2001 180 21-32
62. Paananen R, Sormunen R, Glumoff V et al. Surfactant proteins A and D in Eustachian tube epithelium. Am J Physiol Lung Cell Mol Physiol 2001 281 660-7
63. Kim J K., Kim S S., Rha K W. et al. Am J Physiol Lung Cell Mol Physiol 2007 292 879-884
64. Mo Y K., Kankavi O, Masci P P. et al. Surfactant protein expression in human skin: evidence and implications. J Invest Dermatol 2007 127 381-386
65. Sati L, Seval-Celik Y. Ramazan Demir Lung surfactant proteins in the early human placenta. Histochem Cell Biol
66. Bräuer L, Möschter S, Beileke S et al. Human parotid and submandibular glands express and secrete surfactant proteins A, B, C and D. Histochem Cell Biol 2009 132 (3) 331-338
67. McCulley J P., Shine W E. Meibomian gland function and the tear lipid layer. Ocul Surf 2003 1 97-106
68. Gipson I K., Hori Y, Argueso P et al. Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf 2004 2 131-148
69. Jumblatt M M., McKenzie R W., Steele P S. et al. MUC7 expression in the human lacrimal gland and conjunctiva. Cornea 2003 22 41-45
70. Paulsen F, Langer G, Hoffmann W et al. Human lacrimal gland mucins. Cell Tissue Res 2004 316 167-177
71. Paulsen F. Cell and molecular biology of human lacrimal gland and nasolacrimal duct mucins. Int Rev Cytol 2006 249 229-279
72. Paulsen F, Berry M. Mucins and TFF peptides of the tear film and lacrimal apparatus. Prog Histochem Cytochem 2006 41 1-53
73. Madsen J, Kliem A, Tornoe I et al. Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol 2000 164 5866-5870
74. Stahlman M T., Gray M E., Hull W M. et al. Immunolocalization of surfactant protein-D (SP-D) in human fetal, newborn, and adult tissues. J Histochem Cytochem 2002 50 651-660
75. Akiyama J, Hoffman A, Brown C et al. Tissue distribution of surfactant proteins A and D in the mouse. J Histochem Cytochem 2002 50 993-996
76. Ni M, Evans D J., Hawgood S et al. Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect Immun 2005 73 2147-2156
77. Dobbie J W., Tasiaux N, Meijers P et al. Lamellar bodies in synoviocytes, mesothelium and specific epithelia as possible site of auto-antigen in rheumatoid disease. Br J Rheumatol 1994 33 508-519
78. Diebold Y, Calonge M, Enriquez de Salamanca A. Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci 2003 44 4263-4274
79. Araki-Sasaki K, Ohashi Y, Sasabe T. An SV 40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci 1995 36 614-621
80. Heiligenhaus A, Koch J M., Kruse F E. et al. Diagnostik und Differenzierung von Benetzungsstörungen. Ophthalmologe 1995 92 6-11
81. Narayanan S, Miller W L., McDermott A M. Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease. Invest Ophthalmol Vis Sci 2003 44 3795-3801
82. Sorensen G L., Madsen J, Kejling K et al. Surfactant protein D is proatherogenic in mice. Am J physiol Hear Circ Physiol 2006 290 H2286-H2294
83. Bräuer L, Paulsen F. Tear film and ocular surface surfactants. J Epithelial Biol Pharmacol 2008 1 62-67